Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Ayoub

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Blood Cancer Journal|May 16, 2023
Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimeticsBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Blood|July 3, 2025
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemiaBing Z Carter, Po Yee Mak, Edward Ayoub, et al.
Cancers|January 21, 2023
3q26.2/<i>MECOM</i> Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic FeaturesZhenya Tang, Wei Wang, Su Yang, et al.
Leukemia|March 8, 2024
Correction: Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemiaHiroki Akiyama, Ran Zhao, Lauren B Ostermann, et al.
Leukemia|December 26, 2023
Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemiaHiroki Akiyama, Ran Zhao, Lauren B Ostermann, et al.
Leukemia & Lymphoma|September 12, 2022
Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of <i>TP53</i> alterations and venetoclax treatmentHussein A Abbas, Edward Ayoub, Hanxiao Sun, et al.
Science Advances|November 29, 2023
Enhanced <i>TP53</i> reactivation disrupts <i>MYC</i> transcriptional program and overcomes venetoclax resistance in acute myeloid leukemiasYuki Nishida, Jo Ishizawa, Edward Ayoub, et al.
Blood Cancer Discovery|April 14, 2026
Integrated analysis of genomics, molecular responses and outcomes of CBF-AML with FLAG based therapy on a phase 2 trialJayastu Senapati, Hagop M Kantarjian, Edward Ayoub, et al.
The Journal of Clinical Investigation|June 16, 2026
Elevated mitochondrial protein import in acute myeloid leukemia increases reliance on mitochondrial protease LONP1Matthew Tcheng, Veronique Voisin, Geethu Emily Thomas, et al.
American Journal of Human Genetics|April 26, 2016
Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie SyndromeSylvie Gerber, Kamil J Alzayady, Lydie Burglen, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood Cancer Journal|May 16, 2023
Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimeticsBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Blood|July 3, 2025
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemiaBing Z Carter, Po Yee Mak, Edward Ayoub, et al.
Cancers|January 21, 2023
3q26.2/<i>MECOM</i> Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic FeaturesZhenya Tang, Wei Wang, Su Yang, et al.
Leukemia|March 8, 2024
Correction: Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemiaHiroki Akiyama, Ran Zhao, Lauren B Ostermann, et al.
Leukemia|December 26, 2023
Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemiaHiroki Akiyama, Ran Zhao, Lauren B Ostermann, et al.
Leukemia & Lymphoma|September 12, 2022
Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of <i>TP53</i> alterations and venetoclax treatmentHussein A Abbas, Edward Ayoub, Hanxiao Sun, et al.
Science Advances|November 29, 2023
Enhanced <i>TP53</i> reactivation disrupts <i>MYC</i> transcriptional program and overcomes venetoclax resistance in acute myeloid leukemiasYuki Nishida, Jo Ishizawa, Edward Ayoub, et al.
Blood Cancer Discovery|April 14, 2026
Integrated analysis of genomics, molecular responses and outcomes of CBF-AML with FLAG based therapy on a phase 2 trialJayastu Senapati, Hagop M Kantarjian, Edward Ayoub, et al.
The Journal of Clinical Investigation|June 16, 2026
Elevated mitochondrial protein import in acute myeloid leukemia increases reliance on mitochondrial protease LONP1Matthew Tcheng, Veronique Voisin, Geethu Emily Thomas, et al.
American Journal of Human Genetics|April 26, 2016
Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie SyndromeSylvie Gerber, Kamil J Alzayady, Lydie Burglen, et al.
Pageof 2